Acute and subchronic toxicity as well as mutagenic evaluation of essential oil from turmeric (Curcuma longa L)

Food and Chemical Toxicology

Volumn 53, Issue , 2013, Pages 52-61

  Liju, Vijayasteltar B ^a   Jeena, Kottarapat ^a   Kuttan, Ramadasan ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

Genotoxicity; Mutagenecity; Subchronic toxicity; Turmeric essential oil; Wistar rats

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CURCUMA LONGA EXTRACT; ESSENTIAL OIL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; AUTOPSY; BODY WEIGHT; CHROMOSOME ABERRATION; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; FEMALE; FLUID INTAKE; FOOD INTAKE; GENOTOXICITY; HEMATOLOGICAL PARAMETERS; HISTOPATHOLOGY; KIDNEY FUNCTION; LIVER FUNCTION; MALE; MICRONUCLEUS; MICRONUCLEUS TEST; MUTAGEN TESTING; MUTAGENICITY; NONHUMAN; OPHTHALMOLOGY; ORGAN WEIGHT; RAT; SALMONELLA TYPHIMURIUM; TOXICITY TESTING; URINALYSIS;

ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; CHROMOSOME ABERRATIONS; COMET ASSAY; CURCUMA; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MUTAGENS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; OILS, VOLATILE; ORGAN SIZE; PLANT EXTRACTS; RATS; RATS, WISTAR; SALMONELLA TYPHIMURIUM; TOXICITY TESTS, ACUTE; TOXICITY TESTS, SUBCHRONIC; URINALYSIS;

ANIMALIA; CURCUMA LONGA; RATTUS; RATTUS NORVEGICUS; SALMONELLA TYPHIMURIUM;

EID: 84871464088     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.11.027     Document Type: Article

References (36)

1. Ames B.N., Mccann J., Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat. Res. 1975, 31(6):347-364.
2. Anand P., Thomas S.G., Kunnumakkara K.B., Sundaram C., Harikumar K.B., Sung B., Tharakan S.T., Misra K., Priyadarsini I.K., Rajasekharan K.N., Aggarwal B.B. Biological activities of curcumin and its analogues (Congeners) made by man and mother nature. Biochem. Pharmacol. 2008, 76(11):1590-1611.
3. Antony B., Merina B., Iyer V.S., Judy N., Lennertz K., Joyal S. A pilot cross-over study to evaluate human oral bioavailability of BCM-95 CG (Biocurcumax), a novel bioenhanced preparation of curcumin. Indian J. Pharm. Sci. 2008, 70(4):445-449.
4. Balaji S., Chempakam B. Toxicity prediction of compounds from turmeric (Cucuma longa L). Food Chem. Toxicol. 2010, 48(10):2951-2959.
5. Chandra D., Gupta S.S. Anti-inflammatory and anti-arthritic activity of volatile oil of Curcuma longa (Haldi). Indian J. Med. Res. 1972, 60(1):138-142.
6. Cole T.G., Klotzsch S.G., McNamara J. Measurement of triglyceride concentration. Handbook of Lipoprotein Testing 1997, 115-126. AACC Press, Washington. N. Riafi, G.R. Warnick, M.H. Dominiczak (Eds.).
7. Deeg R., Ziegenhorn J. Kinetic enzymatic method for automated determination of total cholesterol in serum. Clin. Chem. 1983, 29:1798-1802.
8. Deepa Das A., Balan Anita., Sreelatha K.T. Comparative study of the efficacy of curcumin and turmeric oil as chemopreventive agents in oral submucous fibrosis: a clinical and histopathological evaluation. JIAOMR 2010, 22:88-92.
9. Dohare P., Varma S., Ray M. Curcuma oil modulates the nitric oxide system response to cerebral ischemia/reperfusion injury. Nitric Oxide 2008, 19(1):1-11.
10. Funk J.L., Frye J.B., Oyarzo J.N., Zhang H., Timmermann M.N. Anti-Arthritic effects and toxicity of the essential oils of turmeric (Curcuma longa L). J. Agric. Food Chem. 2010, 58(2):842-849.
11. Hastak K., Lubri N., Jakhi S.D., More C., John A., Ghaisas S.D., Bhide S.V. Effect of turmeric oil and oleoresin on cytogenetic damage in patients suffering from oral submucous fibrosis. Cancer Lett. 1997, 116(2):265-269.
12. Hilaly J.E., Israili Z.H., Lyouss B. Acute and chronic toxicological studies of Ajuva iva in experimental animals. J. Ethnopharmacol. 2004, 91(1):43-50.
13. Jaffe M. Uber den Niederschlag, welchen Pikrinsaure in normalen Harn erzeugt und uber neue Reaktion des Kreatinines. Hoppe-Seylers Zeitschrift fur Physiologische Chemie 2003, 10:391-400.
14. Jain V., Prasad V., Pal R., Singh S. Standardization and stability studies of neuroprotective lipid soluble fraction obtained from Curcuma longa. J. Pharm. Biomed. Anal. 2007, 44(5):1079-1086.
15. Jayaprakasha G.K., Jena B.S., Negi P.S., Sakariah K.K. Evaluation of antioxidant activities and antimutagenicity of turmeric oil: a byproduct from Curcumin production. Z Naturforsch C 2002, 57(9-10):828-835.
16. Jendrassik L., Gróf P. Vereinfachte photometrische Methoden zur Bestimmung des Blutbilirubins. Biochem. Zeitschrift. 1938, 297:82-89.
17. Joshi J., Ghaisas S., Vaidya A., Vaidya R., Kamat D.V., Bhagwat A.N., Bhide S. Early human safety study of turmeric oil (Curcuma longa oil) administered orally in healthy volunteers. J. Assoc. Physicians India 2003, 51(11):1055-1060.
18. Kaplan A., Jack R., Opheim K.E., Toivola B., Lyon A.W. Clinical Chemistry Interpretation and Techniques 1995, Wil liams & Wilkins, USA. fourth ed.
19. Krishnaswamy K. Traditional Indian spices and their health significance. Asia Pac. J. Clin. Nutr. 2008, 17(1):265-268.
20. Lameire N., Van Biesen W., Vanholder R. Acute renal failure. Lancet 2005, 365(9457):417-430.
21. Lantz R.C., Chen G.J., Solyom A.M., Jolad S.D., Timmermann B.N. The effect of turmeric extract on inflammatory mediator production. Phytomedicine 2005, 12(6):445-452.
22. Liju V.B., Jeena K., Kuttan R. An evaluation of antioxidant, anti-inflammatory, and antinociceptive activities of essential oil from Curcuma longa L. Indian J. Pharm. 2011, 43(5):526-531.
23. Mc Comb R.B., Bowers G.N. Alkaline Phosphatase 1979, Plenum Press, New York.
24. Negi P.S., Jayaprakasha G.K., Jagan Mohan R.L., Sakariah K.K. Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. J. Agric. Food Chem. 1999, 47(10):4297-4300.
25. Nelson D.A., Morrie M.W. Basic Methodology. Clinical Diagnosis and Management by Laboratory Methods 1984, 589. Saunders, PP, Philadelphia. J.B. Henry (Ed.).
26. Pal G.K., Parvati P. Textbook of Practical Physiology 2003, Orient Longman Private Limited, India.
27. Pearlman F.C., Lee R.T. Detection and measurement of total bilirubin in serum, with use of surfactants as solubilizing agents. Clin. Chem. 1974, 20(4):447-453.
28. Prakash P., Misra A., Surin W.R., Jain M., Bhatta R.S., Pal R., Barthwal M.K., Dikshit M. Anti-platelet effects of curcuma oil in experimental models of myocardial ischemia-reperfusion and thrombosis. Thromb. Res. 2011, 127(2):111-118.
29. Rahman M.F., Siddiqui M.K., Jamil K. Effects of vepacide (Azadirachta indica) on aspartate and alanine aminotransferase profiles in a subchronic study with rats. Hum. Exp. Toxicol. 2001, 20(5):243-249.
30. Rathore P., Dohare P., Varma S., Ray A., Sharma U., Jagannathan N.R., Ray M. Curcuma oil: reduces early accumulation of oxidative product and is anti-apoptogenic in transient focal ischemia in rat brain. Neurochem. Res. 2008, 33(9):1672-1682.
31. Ruby A.J., Kuttan G., Babu K.D., Rajasekharan K.N., Kuttan R. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett. 1995, 94(1):79-83.
32. Sacchetti G., Maietti S., Muzzoli M., Scaglianti M., Manfredini S., Radice M. Comparative evaluation of 11 essential oils of different origins as functional antioxidants, antiradicals and antimicrobials in foods. Food Chem. 2005, 91(4):621-632.
33. Savage J.R.K. Induction and Consequences of Structural Chromosome Aberration. The Biological Basis of Radiotherapy 1983, 93-103. Elsevier Science Publishers, BV. G.G. Steel, G.E. Adams, M.J. Peckham (Eds.).
34. Schmid W. The micronucleus test. Mutat. Res. 1975, 31(1):9-15.
35. Singh N.P. Microgels for estimation of DNA strand breaks, DNA-protein cross links and apoptosis. Mutat. Res. 2000, 455(1-2):111-127.
36. Tofovic S.P., Jackson E.K. Effects of long-term caffeine consumption on renal function in spontaneously hypertensive heart failure prone rats. J. Cardiovasc. Pharmacol. 1999, 33(3):360-366.